Dr. Eve Mylchreest
This October, Battelle welcomed Dr. Eve Mylchreest to the Life Sciences Research team. She brings deep expertise in the area of developmental and reproductive toxicology (DART) that will be invaluable to our government, industrial and pharmaceutical clients. In her new role as Research Leader, she will be focused on expanding Battelle’s capabilities in these areas.
Eve has more than 15 years of experience as a Study Director and more than 20 years of experience in reproductive and developmental toxicology. She has conducted over 70 reproductive and developmental toxicology studies for clients in the industrial, agrochemical, and pharmaceutical industries. Her work on the effects of di(n-butyl) phthalate on male reproductive development was pivotal in the risk assessment of di(n-butyl) phthalate by the National Toxicology Program. The papers she has published on this area are among the ten most frequently cited papers in the journal Toxicological Sciences.
In addition to leading research studies for our commercial clients, Eve will provide ongoing support for the National Toxicology Program. NTP is a Department of Health and Human Services program that coordinates toxicology research and testing for thousands of chemicals with potential human health concern. Her work will help the NTP determine the effects of pre-natal and post-natal exposure to certain chemicals on development.
Prior to coming to Battelle, Eve worked as a Program Leader for Developmental and Reproductive Toxicology (DART) for the Southern Research Institute and as a Principal Research Scientist for Pfizer, among other roles for commercial organizations. She holds a Ph.D in Toxicology, an M.S. in Toxicology, and a B.S. in Biochemistry from the Université de Montréal.